dl 473 , a new semisynthetic rifamycin , was 2-10 times more active in vitro than rifampicin ( ramp ) against several clinical isolates of mycobacterium tuberculosis and only slightly less active than ramp against gram-positive and gram-negative bacteria .
C0035609
rifamycin
C0035608
ramp